US 9198893
Combination antitumor therapy
granted A61KA61K31/28A61K31/337
Quick answer
US patent 9198893 (Combination antitumor therapy) held by Galera Labs, LLC expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Galera Labs, LLC
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/28, A61K31/337, A61K31/555, A61K45/06